Important Update on Prescription Forms for TMB and TSBP Licensees

Health & LifestylePublisher's Picks
477

Listen to article (english)

Translate to Spanish or other 102 languages!

Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe. Image for illustration purposes
Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe. Image for illustration purposes

Mega Doctor News

- Advertisement -

 By the Texas Medical Association

As many of our licensees are aware, the recent cyberattack on Change Healthcare has hampered some patients’ ability to obtain certain necessary prescription medications.    

The Texas Medical Board (TMB), in conjunction with the Texas State Board of Pharmacy (TSBP), would like to take this opportunity to remind prescribers that during times when electronic prescribing is unavailable, practitioners are able to utilize the official, physical Schedule II prescription form provided by the TSBP.  These forms may be ordered online via the TSBP’s website at www.pharmacy.texas.gov/PMP/CIIforms.asp.  

- Advertisement -

Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe.   

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Trans Advocacy Group Sues Attorney General in Effort to Hide Incriminating Documents
Next article
How Colorectal Cancer Differs in Younger Adults

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -